Breast Cancer Clinical Trial
Official title:
Mindful Movement for Breast Cancer Survivors
| Verified date | July 2017 |
| Source | John Wayne Cancer Institute |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to determine if participating in a Mindful Movement Program (MMP) (learning how to be mindful in one's movement), positively affects the body's immune functions improves mindfulness and reduces worries about cancer returning. All participants will be in this study about three months.
| Status | Completed |
| Enrollment | 24 |
| Est. completion date | June 2017 |
| Est. primary completion date | June 2017 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 50 Years and older |
| Eligibility |
Inclusion Criteria: - diagnosed at age 50 or older with stage 0-III disease - 6 months or more since completion of primary breast cancer treatment - have a medical release from their physician - English-speaking - not pregnant - no weekly practice of yoga, qi gong, tai chi, dance/movement therapy, or mindfulness meditation practice Exclusion Criteria: - Males with breast cancer |
| Country | Name | City | State |
|---|---|---|---|
| United States | Margie Petersen Breast Center at Providence Saint John's Health Center | Santa Monica | California |
| Lead Sponsor | Collaborator |
|---|---|
| John Wayne Cancer Institute |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Fear of Recurrence | Fear of recurrence as measured on Fear of Recurrence (FOR) scale | 18 weeks | |
| Other | Mindfulness attention | Improvement in mindfulness attitude as measured with the Mindful Attention Awareness Scale (MAAS) | 18 weeks | |
| Other | Mindfulness attitude | Improvement in mindfulness attitude as measured with the Experiences Questionnaire (EQ) | 18 weeks | |
| Primary | Immune markers | Improvement in serum markers of immune cell phenotype at week 18 | 18 weeks | |
| Secondary | Mindful Movement Intervention Experience | Improvement in mindfulness attitude as measured on Meditative Movement Inventory (MMI) | 18 weeks | |
| Secondary | Mindful Movement Intervention Experience | Improvement in mindfulness attitude as measured on Perceived Exertion Scale (PES) | 18 weeks | |
| Secondary | Mindful Movement Intervention Experience - Mindfulness Intention | Improvement in mindfulness attitude as measured on Mindfulness Intention (modified from Segal, 1-item) | 18 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |